Bio Essence Corp
BIOE· OTC
BIOEBio Essence Corp
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001213900-23-066865
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $259.57K | $288.14K | $235.93K | $205.09K |
| Net Income | -$284.52K | -$164.19K | -$163.54K | -$184.45K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end
